Lipodystrophies Completed Phase 2 Trials for Lamivudine (DB00709)

Also known as: Lipodystrophy / Lipodystrophy NOS / Lipodystrophy acquired

IndicationStatusPhase
DBCOND0026618 (Lipodystrophies)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00021463Changing to Nonprotease Inhibitor Treatment to Improve Side EffectsTreatment